265 completed, 56 recruiting, 39 unknown, 33 terminated. 124 Not applicable, 119 Phase 2, 85 Phase 3, 34 Phase 1, 29 Phase 4.
Follow Eczema: new trials by email Literature Review of Eczema trials Research Report on Eczema
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Abrocitinib Treatment of Atopic Dermatitis in Children 2 to Less Than 6 Years of Age Abrocitinib, Placebo - Atopic Dermatitis | Phase 3 | Not yet recruiting | Pfizer | 90 | 2027-05-01 | 2026-09-16 |
| Educational Eczema Video Intervention in-clinic video intervention, at home video intervention - Eczema | Not applicable | Withdrawn | Boston Children's Hospital | 2027-01-01 | 2026-10-19 | |
| Moisturization and Skin Hydration Study Moisturizing while in shower/bath, Moisturizing after towel drying - Atopic Dermatitis (AD), Atopic Dermatitis (Eczema) | Not applicable | Not yet recruiting | University of British Columbia | 30 | 2027-01-01 | 2026-11-16 |
| Study of Multiple Ascending Doses (MAD) of M5542 in Participants With Moderate and Severe Eczema M5542 - Eczema | Phase 1 | Not yet recruiting | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 56 | 2026-12-20 | 2026-11-12 |
| Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis Digital App Mindfulness Meditation, Mindfulness Meditation Sheet - Atopic Dermatitis, Eczema | Not applicable | Recruiting | Weill Medical College of Cornell University | 40 | 2026-11-15 | 2026-10-23 |
| A Clinical Trial to Evaluate the Effects of Broc Shot Capsules on Skin Appearance and Comfort in Adults With Reactive, Blemish-Prone, or Hormonally Affected Skin Broc Shot Capsules Intervention, Placebo Intervention - Reactive Skin, Blemish-Prone Skin | Not applicable | Not yet recruiting | BrocShot Inc | 50 | 2026-11-01 | 2026-11-18 |
| Roflumilast Cream 0.3% for Moderate to Severe Atopic Dermatitis Roflumilast Cream 0.3%, Vehicle Cream - Atopic Dermatitis, Atopic Dermatitis (AD) | Phase 3 | Recruiting | Arcutis Biotherapeutics, Inc. | 415 | 2026-10-30 | 2026-11-06 |
| Evidencing Vibroacoustic Sensing for Inflammatory Skin Disease Monitoring Vibroacoustic sensing device - Eczema, Psoriasis | Not yet recruiting | University of Edinburgh | 20 | 2026-10-01 | 2026-09-29 | |
| Skin-in-Sight: a Longitudinal Cohort Infrastructure for Standardized Remote Monitoring and the Evaluation of Digital Care Innovations in Chronic Skin Diseases Psoriasis, Eczema/Atopic Dermatitis | Not yet recruiting | Medisch Spectrum Twente | 1000 | 2026-10-01 | 2026-09-04 | |
| Retention of Vernix Caseosa in Newborns for Primary Prevention of Atopic Dermatitis Retention of Vernix Caseosa After Birth, Removal of Vernix Caseosa After Birth - Atopic Dermatitis | Not applicable | Recruiting | Pontificia Universidad Catolica de Chile | 1383 | 2026-09-29 | 2026-09-30 |
| A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in Dermatology Flexible ePROM-guided Scheduling System, electronic patient reported outcome measures (ePROMs) - Chronic Dermatological Conditions, Eczema | Not applicable | Not yet recruiting | National University Hospital, Singapore | 250 | 2026-09-01 | 2026-07-01 |
| Multi-Omic SignAtures of Inflammatory Cutaneous Diseases Inflammatory Skin Conditions | Not yet recruiting | Guy's and St Thomas' NHS Foundation Trust | 400 | 2026-09-01 | 2026-08-18 | |
| A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema Tilrekimig, Dupilumab, Placebo for Tilrekimig - Atopic Dermatitis | Phase 3 | Recruiting | Pfizer | 1375 | 2026-08-24 | 2026-11-06 |
| A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema Tilrekimig, Placebo - Atopic Dermatitis | Phase 3 | Recruiting | Pfizer | 375 | 2026-08-17 | 2026-11-12 |
| The Impact of Dietary Salt on the Severity of Eczema Sodium chloride tablets, Placebo Tablets - Eczema, Atopic Dermatitis | Phase 4 | Recruiting | University of California, San Francisco | 40 | 2026-08-10 | 2026-09-10 |
| Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream. Roflumilast Cream 0.15% - ITCH, Atopic Dermatitis | Phase 4 | Recruiting | Integrative Skin Science and Research | 40 | 2026-07-21 | 2026-08-13 |
| The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease Sodium chloride tablets, Placebo Tablets - Atopic Dermatitis (Eczema), Psoriasis | Phase 4 | Recruiting | University of California, San Francisco | 50 | 2026-07-14 | 2026-09-09 |
| A Clinical Trial to Evaluate the Effects of Rejuvaskin Eczema Body Wash and Skin Recovery Cream in Adults With Eczema-Prone Skin Rejuvaskin Eczema Body Wash - Eczema, Atopic Dermatitis | Not applicable | Active not recruiting | Rejuvaskin | 35 | 2026-07-06 | 2026-07-14 |
| Study the Mechanism and Effectiveness of Probiotics on Atopic Dermatitis Probiotic 2 × 10^8, Placebo capsule, Probiotic 2 × 10^10 - Atopic Dermatitis, Eczema | Not applicable | Enrolling by invitation | National Cheng-Kung University Hospital | 90 | 2026-06-30 | 2026-11-16 |
| Reflectance Confocal Microscopy Evaluation of Skin Structure of Patients With Atopic Dermatitis Under Nemolizumab Atopic Dermatitis (AD), Atopic Dermatitis (Eczema) | Recruiting | Hôpitaux Drôme Nord | 15 | 2026-06-11 | 2026-07-28 |
Showing 20 of 460. Sign in to see all of them.
Dermatitis, Atopic (328) · Dermatitis (80) · Skin Diseases (52) · Pruritus (45) · Hypersensitivity (34) · Psoriasis (32) · Asthma (27) · Immune System Diseases (19) · Skin Diseases, Eczematous (17) · Food Hypersensitivity (16) · Skin Diseases, Genetic (15) · Acne Vulgaris (10) · Hypersensitivity, Immediate (9) · Genetic Diseases, Inborn (8)
Skin and Connective Tissue Diseases (460) · Skin Diseases, Eczematous (443) · Skin Diseases (408) · Dermatitis (380) · Immune System Diseases (355) · Hypersensitivity, Immediate (350) · Hypersensitivity (337) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (332) · Genetic Diseases, Inborn (324) · Skin Diseases, Genetic (315) · Pathological Conditions, Signs and Symptoms (72) · Signs and Symptoms (63) · Skin Manifestations (45) · Respiratory Tract Diseases (35) · Skin Diseases, Papulosquamous (33)
dupilumab (20) · abrocitinib (16) · lebrikizumab (16) · baricitinib (10) · Adrenal Cortex Hormones (6) · pimecrolimus (6) · Blood Specimen Collection (4) · Exercise (4) · gusacitinib (4) · Betamethasone (3) · Ointments (3) · Petrolatum (3) · Probiotics (3) · R-1,1,1-trifluoro-4-(5-fluoro-2,3-dihydrobenzofuran-7-yl)-4-methyl-2-(((2-methyl-5-quinolyl)amino)methyl)pentan-2-ol (3) · Triamcinolone (3)
Pfizer (25) · Eli Lilly and Company (22) · Regeneron Pharmaceuticals (11) · Incyte Corporation (10) · National Institute of Allergy and Infectious Diseases (NIAID) (9) · Novartis Pharmaceuticals (8) · University of California, San Francisco (7) · Organon and Co (6) · Almirall, S.A. (5) · Amgen (5) · National University Hospital, Singapore (5) · Arcutis Biotherapeutics, Inc. (4) · Asana BioSciences (4) · Bayer (4) · Codex Labs Corporation (4)
United States (236) · Canada (96) · Germany (71) · Poland (66) · Spain (42) · United Kingdom (42) · Japan (39) · Australia (38) · Czechia (33) · France (29) · China (26) · Hungary (25) · Taiwan (24) · Italy (21) · Bulgaria (20)
David Zammit, Ph.D. (4) · Diana Villalobos (4) · Eric Simpson, MD (3) · Lisa Beck, MD (3) · Amisha Parikh-Das, PhD (2) · Arine M Vlieger, MD, PhD (2)
PMID 33826132, PMID 42162528, PMID 34406619, PMID 36255569, PMID 39588375, PMID 36749121, PMID 38896380, PMID 39104653, PMID 40028832, PMID 33982267, PMID 34275122, PMID 34688290, PMID 35342978, PMID 35567671, PMID 38777187, PMID 40383273, PMID 40600584, PMID 40993471, PMID 41206702, PMID 42365219, PMID 31595499, PMID 33222559, PMID 33481203, PMID 33658996, PMID 33899152, PMID 33954933, PMID 33957195, PMID 34270797, PMID 34427891, PMID 34743361, PMID 35061234, PMID 35462428, PMID 35763326, PMID 36184023, PMID 36264430, PMID 36723913, PMID 36920778, PMID 36994947, PMID 37750994, PMID 37949351, PMID 37988255, PMID 38679419, PMID 38698175, PMID 38700646, PMID 38743155, PMID 38922484, PMID 39002092, PMID 39123054, PMID 39249591, PMID 39375281
2018 (12), 2023 (10), 2019 (8), 2017 (5), 2025 (3), 2015 (2), 2016 (2), R21AR062357 (2), 2008 (1), 2014 (1), K24HD069408 (1), R01AR071057 (1), R01AR073486 (1), R01AR082831 (1), R01HD050758 (1)